Phase I Dasatinib/Erlotinib in Recurrent Non-small Cell Lung Cancer (NSCLC)

Clinical trial NCT00444015 · COMPLETED

Trial details

NCT number: NCT00444015
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Small-Cell Lung Carcinoma

Start date: 2007-03-01
Primary completion: 2010-08-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.